CN Patent

CN119700926A — 血管紧张素ii单独或以组合方式用于治疗低血压

Assigned to George Washington University · Expires 2025-03-28 · 1y expired

What this patent protects

本发明尤其涉及这样一种方法，其包括对具有高输出休克和经历用相当于至少约0.2mcg/kg/min去甲肾上腺素的剂量的儿茶酚胺治疗的受试者施用这样的剂量的血管紧张素II，其有效地将受试者的血压升高到约65mm Hg或以上的平均动脉压(MAP)，并且其有效地降低保持约65mm Hg的MAP所需的儿茶酚胺的剂量至相当于约0.05‑0.2mcg/kg/min的去甲肾上腺素或更少，或至相当于约0.05mcg/kg/min的去甲肾上腺素或更少。

USPTO Abstract

本发明尤其涉及这样一种方法，其包括对具有高输出休克和经历用相当于至少约0.2mcg/kg/min去甲肾上腺素的剂量的儿茶酚胺治疗的受试者施用这样的剂量的血管紧张素II，其有效地将受试者的血压升高到约65mm Hg或以上的平均动脉压(MAP)，并且其有效地降低保持约65mm Hg的MAP所需的儿茶酚胺的剂量至相当于约0.05‑0.2mcg/kg/min的去甲肾上腺素或更少，或至相当于约0.05mcg/kg/min的去甲肾上腺素或更少。

Drugs covered by this patent

angiotensin-ii-acetate (ANGIOTENSIN II ACETATE)

Patent Metadata

Patent number: CN119700926A
Jurisdiction: CN
Classification: —
Expires: 2025-03-28
Drug substance claim: No
Drug product claim: No
Assignee: George Washington University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.